Equities

Orion Biotech Opportunities Corp

ORIA:NAQ

Orion Biotech Opportunities Corp

Actions
  • Price (USD)9.74
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 29 2021 19:15 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Orion Biotech Opportunities Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company intends to focus on the biotechnology and life sciences industries. It has no operations and has generated no revenues.

  • Revenue in USD (TTM)--
  • Net income in USD--
  • Incorporated2021
  • Employees--
  • Location
    Orion Biotech Opportunities Corp645 Fifth Avenue, 21St Floor, 21st FloorNEW YORK 10022United StatesUSA
  • Phone+1 (212) 303-7822
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Infinite Acquisition Corp-100.00bn-100.00bn242.40m-----------------0.0019----------------------------1.40--------------
Frontier Investment Corp-100.00bn-100.00bn243.00m----1.30----------7.45----------------------------0.00--------------
Acacia Research Corp29.17m6.44m243.00m20.0035.431.0915.458.33-0.5124-0.51240.48634.790.0496--86.421,458,400.004.36-2.826.25-3.1995.4480.7687.90-10.66----0.4229--164.82-24.94618.48---6.45--
SLR Senior Investment Corp28.84m18.31m243.14m--13.280.9633--8.431.141.141.8015.730.049------3.113.804.574.9465.6671.2663.4757.47----0.3821112.73-20.674.56-39.3167.79---2.07
Orion Biotech Opportunities Corp-100.00bn-100.00bn243.50m----0.2602----------37.43----------------------------0.00--------------
Neuberger Berman High Yield Strateges Fd20.50m40.54m243.67m--3.391.00--11.893.683.681.8612.420.1063--2.81--21.245.2925.645.37----199.7857.67--19.650.3104186.64-7.18-3.80233.7828.39---5.25
TB SA Acquisition Corp-100.00bn-100.00bn243.75m----1.25----------7.79----------------------------0.00--------------
Build Acquisition Corp-100.00bn-100.00bn244.00m----1.31----------7.48----------------------------0.00--------------
Athena Consumer Acquisition Corp-100.00bn-100.00bn244.21m----11,841.67----------0.0009----------------------------0.00--------------
Eaton Vance Municipal Income2028Trm Trst13.25m12.14m244.44m--20.131.03--18.451.121.121.2221.870.0364--6.26--3.333.183.353.1976.2367.6091.6184.93----0.342480.910.19480.0952-59.45-4.31---0.1416
Monroe Capital Corp53.34m34.70m244.95m0.007.000.9931--4.591.621.622.5011.450.0942--7.01--6.132.406.212.4342.5852.4965.0522.24----0.5733199.88-9.7010.79-91.43-37.95---4.71
Pimco CA Muni. Income Fund III14.97m19.24m244.97m--12.731.06--16.370.85880.85880.668114.690.0379------4.913.364.933.3778.2377.75129.5978.20----0.1728107.61-10.55---54.65------
ME Renewable Power Corp0.00-17.88k245.57m-----------0.0001-0.00010.00-0.0004-----------1,273.56-------------------------208.13------
Sarissa Capital Acquisition Corp0.002.32m246.25m--180.601.34----0.05450.05450.007.370.00------2.30--2.30--------------0.00--------------
Corazon Capital V838 Monoceros Corp-100.00bn-100.00bn247.36m----1.31----------7.38----------------------------0.00--------------
Tuatara Capital Acquisition Corp-100.00bn-100.00bn247.50m----1.35----------7.36----------------------------0.00--------------
Data as of Nov 29 2021. Currency figures normalised to Orion Biotech Opportunities Corp's reporting currency: US Dollar USD

Institutional shareholders

31.08%Per cent of shares held by top holders
HolderShares% Held
683 Capital Management LLCas of 30 Sep 20211.20m6.00%
Fir Tree Capital Management LPas of 30 Sep 20211.00m5.00%
Koch Industries, Inc. (Investment Management)as of 30 Sep 2021800.00k4.00%
MM Asset Management, Inc.as of 30 Sep 2021800.00k4.00%
Arena Capital Advisors LLCas of 30 Sep 2021600.00k3.00%
HighTower Advisors LLCas of 30 Sep 2021591.29k2.96%
Radcliffe Capital Management LPas of 30 Sep 2021400.00k2.00%
Angelo, Gordon & Co. LPas of 30 Sep 2021300.00k1.50%
Marshall Wace LLPas of 30 Sep 2021274.98k1.38%
UBS O'Connor LLCas of 30 Sep 2021250.00k1.25%
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.